
FONAR Corporation FONR
$ 18.41
0.38%
Quarterly report 2025-Q4
added 02-13-2026
FONAR Corporation Interest Expense 2011-2026 | FONR
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense FONAR Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 347 K | 249 K | 74.3 K | 98.6 K | -160 K | 28.3 K | -262 K | -702 K | -885 K | -500 K | 479 K | 515 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 515 K | -885 K | -60 K |
Quarterly Interest Expense FONAR Corporation
| 2025-Q4 | 2025-Q3 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 K | 3 K | -1 K | 1 K | -1 K | 45 K | 10 K | 48 K | 15 K | 12 K | 14 K | -197 K | - | 47 K | 811 K | 858 K | 19 K | 16 K | 22 K | 16 K | 22 K | 19 K | 21 K | -19 K | -21 K | -25 K | -25 K | -25 K | -25 K | -48 K | -43 K | -48 K | -43 K | -77 K | -98 K | -77 K | -98 K | -139 K | -150 K | 139 K | 150 K | 172 K | 204 K | 172 K | 204 K | 237 K | 243 K | 237 K | 243 K | 103 K | 76 K | 103 K | 76 K | 124 K | 107 K | 124 K | 107 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 858 K | -197 K | 65.4 K |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
BioSig Technologies
BSGM
|
23 K | - | 37.08 % | $ 85.7 M | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Orthofix Medical
OFIX
|
8.11 M | $ 11.72 | -1.26 % | $ 464 M | ||
|
LENSAR
LNSR
|
660 K | $ 5.56 | -8.4 % | $ 64 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
AxoGen
AXGN
|
167 K | $ 32.61 | 2.71 % | $ 1.5 B | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 36.56 | -0.19 % | $ 1.13 B | ||
|
Penumbra
PEN
|
893 K | $ 334.17 | -0.41 % | $ 13 B | ||
|
Electromed
ELMD
|
78 K | $ 24.7 | 0.86 % | $ 209 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
Insulet Corporation
PODD
|
14.3 M | $ 225.5 | -0.7 % | $ 15.9 B | ||
|
Aethlon Medical
AEMD
|
10.1 K | $ 2.16 | -6.09 % | $ 3.37 M | ||
|
Profound Medical Corp.
PROF
|
146 K | $ 5.15 | -4.63 % | $ 180 M | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
Quanterix Corporation
QTRX
|
157 K | $ 3.82 | -3.05 % | $ 163 M | ||
|
AdaptHealth Corp.
AHCO
|
-274 K | $ 11.48 | 10.7 % | $ 1.55 B | ||
|
Myomo
MYO
|
-668 K | $ 0.7 | -1.83 % | $ 29.3 M | ||
|
Invacare Corporation
IVC
|
28.5 M | - | - | $ 24.7 M | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 3.91 | 4.83 % | $ 146 M | ||
|
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 15.91 | -3.4 % | $ 373 M | ||
|
Outset Medical
OM
|
14 M | $ 3.53 | -2.35 % | $ 53.7 K | ||
|
Inspire Medical Systems
INSP
|
-2.66 M | $ 52.07 | -0.17 % | $ 1.53 B | ||
|
Sintx Technologies
SINT
|
31 K | $ 2.57 | 0.78 % | $ 7.13 M | ||
|
Pulmonx Corporation
LUNG
|
790 K | $ 1.31 | -5.76 % | $ 53.3 M | ||
|
Cutera
CUTR
|
-244 K | - | -10.19 % | $ 1.99 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Sensus Healthcare
SRTS
|
683 K | $ 3.96 | -3.65 % | $ 64.7 M | ||
|
InspireMD
NSPR
|
200 K | $ 1.79 | 3.47 % | $ 115 M | ||
|
Eargo
EAR
|
549 K | - | - | $ 10.2 M | ||
|
NuVasive
NUVA
|
-21.4 M | - | - | $ 2.07 B | ||
|
Second Sight Medical Products
EYES
|
1.19 M | - | -0.97 % | $ 54.4 M |